Stocktoria

BGM Group Ltd. BGM

Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2021-01-12

BGM Group Ltd. statistics & valuation

Market cap$59.4M
P / S1.6×
P / B0.2×
Net margin-52.6%
Return on equity-5.1%
FCF margin-10.4%
Return on capital-3.2%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Net margin (%)
10.10% 5.50% 1.70% -16.70% -5.70% -52.60% 202020212022202320242025
Gross margin (%)
15.10% 9.90% 9.60% 3.80% 16.40% 16.60% 202020212022202320242025
Operating margin (%)
9.60% 4.20% 3.20% -5.60% -2.20% -33.20% 202020212022202320242025
Return on equity (%)
17.60% 5.60% 2.00% -17.50% -3.30% -5.10% 202020212022202320242025
Shares outstanding
30.0M 35.8M 35.8M 35.8M 7.2M 200.6M 202020212022202320242025
Net debt ($)
202020212022202320242025
Share buybacks ($)
202020212022202320242025
Return on assets (%)
10.50% 4.20% 1.70% -15.20% -2.70% -4.60% 202020212022202320242025
Free cash flow margin (%)
9.20% -2.00% 16.40% 0.30% 1.20% -10.40% 202020212022202320242025
Debt / equity (×)
202020212022202320242025
EPS ($)
$0.17 $0.09 $0.15 -$1.08 -$0.20 -$0.18 202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020
Gross margin16.6%16.4%3.8%9.6%9.9%15.1%
Operating margin-33.2%-2.2%-5.6%3.2%4.2%9.6%
Net margin-52.6%-5.7%-16.7%1.7%5.5%10.1%
FCF margin-10.4%1.2%0.3%16.4%-2.0%9.2%
Return on assets-4.6%-2.7%-15.2%1.7%4.2%10.5%
Return on equity-5.1%-3.3%-17.5%2.0%5.6%17.6%
Current ratio1.243.395.183.272.222.04

Computed from company filings · US · as of 2024-09-30. Facts plus Stocktoria's own computed scores — not investment advice.